

Is Zavzpret in shortage in 2026? Get the latest update on Zavzpret availability, pricing, and what you can do if your pharmacy is out of stock.
If you've been told your pharmacy doesn't have Zavzpret (Zavegepant) in stock, you're probably wondering: is there a shortage? The answer is nuanced — and it matters for how you approach getting your medication.
In this update, we'll cover the current status of Zavzpret availability, why it's hard to find even without a formal shortage, what it costs in 2026, and what options you have right now.
As of early 2026, Zavzpret is not listed on the FDA Drug Shortage Database. This means there is no official, FDA-recognized supply disruption for Zavegepant nasal spray.
However, "not in shortage" doesn't mean "easy to find." The reality on the ground is that many patients report difficulty locating Zavzpret at their local pharmacy. This disconnect between official status and patient experience is common with expensive specialty medications.
The issue isn't that Pfizer can't make enough Zavzpret — it's that many pharmacies choose not to stock it. The reasons come down to economics and logistics, which we'll explain below.
Even without a formal shortage, several factors make Zavzpret challenging to access:
A pack of 8 Zavzpret nasal spray devices costs roughly $800 to $1,100 at cash price. That's a significant inventory investment for a pharmacy that may only have a few patients who use it. Many retail pharmacies, especially large chains, simply don't keep Zavzpret on their shelves.
Most insurance plans require prior authorization for Zavzpret, and many also impose step therapy requirements — meaning you must try and fail a triptan before Zavzpret is approved. These requirements slow down access and can discourage pharmacies from stocking a product that often gets caught in insurance red tape.
Some insurance plans require Zavzpret to be filled at a specialty pharmacy rather than your local retail pharmacy. While specialty pharmacies can be very effective, the enrollment process can take time, and patients may not realize their plan has this requirement until they're already at the pharmacy counter.
There is no generic Zavegepant available in 2026. Without generic alternatives driving prices down and increasing the number of suppliers, access remains constrained to the brand-name product from Pfizer.
For a deeper look at these factors, see our article on why Zavzpret is so hard to find.
Here's a snapshot of Zavzpret pricing:
For full details on how to reduce your costs, read our guide on how to save money on Zavzpret.
The migraine treatment landscape continues to evolve. While Zavzpret remains the only intranasal gepant, other CGRP-based treatments provide solid alternatives:
If you're considering a switch, check out our full alternatives guide.
Here's what we recommend:
Our detailed tips are in the guide on how to find Zavzpret in stock near you.
Zavzpret is not in a formal shortage in 2026 — but it's still not easy to find. The combination of high cost, limited pharmacy stocking, insurance hurdles, and no generic option means patients have to be proactive about access.
The good news is that the medication is available if you know where to look. Tools like Medfinder, manufacturer savings programs, and specialty pharmacies can all help bridge the gap between your prescription and your medicine cabinet.
Stay informed, plan ahead, and don't hesitate to talk to your doctor about your options — whether that's finding Zavzpret or exploring an alternative that works for you.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.